DALLAS, Feb. 4 /PRNewswire/ -- U.S. Preventive Medicine(R), the leader in disease prevention services, announced today that two of its executives -- Christopher Fey, Chairman and CEO, and Fred Goldstein, President -- will speak at the 2009 UBS Global Healthcare Services Conference, to be held February 9-11 in New York City. This marks the third consecutive year U.S. Preventive Medicine will participate in this exclusive conference for the world's health services investment community.
Fey and Goldstein will present an overview of The Prevention Plan(TM), the company's groundbreaking health improvement program that is being rolled out internationally to employers, government agencies and consumers. The Prevention Plan is the first health benefit program in the marketplace developed exclusively to help individuals learn about and address their top health risks as well as help employers and payors lower healthcare costs and increase productivity.
"We are honored to once again have the opportunity to participate in this prestigious gathering of health care investors," said Fey. "The reaction to our recent introduction of The Prevention Plan has been extremely positive in both the employer and broker dealer communities and we look forward to sharing our plans for continued growth in 2009 and beyond at the conference."
The presentation is scheduled for Tuesday, February 10 beginning at 11:30 a.m. EST and will take place at the Waldorf=Astoria Hotel.
An audio webcast of the presentation will be available at
About U.S. Preventive Medicine(R)
U.S. Preventive Medicine(R), a privately-owned global prevention services company with clients nationwide and the United Kingdom, provides primary, secondary and tertiary clinical prevention services to government, employers and consumers that are data-driven and outcomes-oriented. Company products include the world's first preventive health benefit, The Prevention Plan(TM), available to buy or test drive at www.USPreventiveMedicine.com and www.ThePreventionPlan.com.
|SOURCE U.S. Preventive Medicine|
Copyright©2009 PR Newswire.
All rights reserved